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ABSTRACT 
Objective: Attention-deficit/hyperactivity disorder (ADHD) is more frequent in males than 
females. The “female protective effect” posits that females undergo greater exposure to 
etiological factors than males in order to develop ADHD, leading to the prediction that 
relatives of females with ADHD will display more ADHD behaviors.  We thus tested 
whether co-twins of females displaying extreme ADHD traits would display more ADHD 
traits than co-twins of males displaying extreme ADHD traits.   
Method: Parents of approximately 7,000 pairs of non-identical twins in Sweden, and around 
4,000 pairs of twins in England and Wales, completed dimensional assessments of ADHD 
traits. Probands were selected on the basis of scoring within the highest 10% of the 
distribution in each sample. Dimensional scores of co-twins of probands, as well as the 
categorical recurrence rate, were investigated by proband sex.   
Results: Co-twins of female probands displayed higher mean ADHD trait scores (̅=0.62-
0.79) than co-twins of male probands (̅=0.38-0.55) in both samples. This trend was 
significant in the Swedish sample (p<.01) and when the two samples were merged into a 
single, larger sample (p<.001). When the samples were merged, there was also a significant 
association between proband sex and co-twin’s categorical status, with more co-twins of 
female probands also being probands than co-twins of male probands.  
Conclusion: These findings support a female protective effect against ADHD behaviors, 
suggesting that females require greater exposure to genetic and environmental factors 
associated with ADHD in order to develop the condition. 
Key words: ADHD, sex differences, genetics, twin study  
INTRODUCTION  
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition 
characterized either by excessive hyperactivity and impulsivity, inattentiveness, or a 
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combination of these symptoms1. Epidemiological studies suggest that, overall, ADHD 
affects between 5-7% of the population2. Notably, ADHD appears to be substantially more 
common in males than females. A study of ten European countries, for instance, indicated 
that males with ADHD outnumbered females with ADHD by ratios of two to one to sixteen 
to one3. The excess of males with ADHD has been further confirmed by meta-analyses, with 
four times as many males than females thought to be affected2,4.  
A number of twin studies have established that ADHD is among the most heritable of 
neuropsychiatric conditions5-9. The high heritability of ADHD does not vary markedly 
whether it is conceptualized as a categorical, diagnosed condition5-6 or treated as a continuous 
trait in the general population7-9, thus indicating that severe forms of ADHD may be linked 
genetically with milder, subclinical traits of ADHD in the general population. Such studies, 
however, have yet to shed light on the reasons why ADHD appears to be so much more 
common in males than females.  
One possible explanation for the sharp sex discrepancy in ADHD prevalence is a 
putative “female protective effect” model. Under this model, females would be predicted to 
require greater exposure to genetic and environmental factors associated with ADHD than 
males in order to display sufficient ADHD behaviors to warrant a diagnosis, thus meaning 
that fewer females would be expected to be diagnosed with ADHD than males10-11. As such, 
one would expect more causal factors to be present in the families of females with ADHD, 
leading to the prediction that ADHD and ADHD behaviors will be more prevalent in the 
relatives of females with ADHD. The female protective effect is presently receiving 
considerable attention in relation to autism spectrum disorders (ASD), which are similarly 
male-biased conditions. In one study, for example, the fraternal co-twins of females 
displaying a high degree of autistic traits displayed more autistic traits than did co-twins of 
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males with high degrees of autistic traits, and were also more likely to display high scores 
themselves12.  
Very few studies have tested for the existence of a female protective effect against 
ADHD. A recent Swedish investigation suggested that merely having a female co-twin is 
associated with displaying a greater degree of ADHD traits than having a male co-twin, 
although this study did not take account of the degree to which the index twin displayed 
ADHD symptoms13. In one study of a US-based twin sample, traits of ADHD were examined 
in the co-twins of individuals displaying a high degree of traits of ADHD. Co-twins of 
females displaying extreme ADHD traits displayed significantly greater ADHD-like 
behaviors than the co-twins of males displaying extreme traits of ADHD14. Of note, however, 
the effect was not present for the co-twins of the most severely affected twins, perhaps owing 
to the small effect size and lower number of twins displaying the very highest scores.  
As a consequence, we aimed to test for the existence of a female protective effect 
against ADHD behaviors in two independent, large-scale European twin samples. We first 
tested whether the co-twins of females displaying extreme degrees of ADHD traits would 
exhibit more continuous ADHD traits than the co-twins of high-scoring males. Second, we 
sought to test whether high-scoring female twins were more likely to have a high-scoring co-
twin than high-scoring male twins. The one previous study documenting this effect reported 
that the effect size was small14; thus, we not only aimed to test for the female protective 
effect against ADHD in our two samples independently, but also pooled the two samples to 
increase power. We expected, in light of existing evidence, to find evidence of a female 
protective effect against ADHD behaviors13-14.     
METHOD 
Participants 
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Data were collected from participants in two representative, community-based twin 
studies. The Child and Adolescent Twin Study in Sweden (CATSS) is a study of twins born 
in Sweden since 1992. Initially, the twins were contacted in connection with their ninth 
birthdays15. For the present study, data were collected from twins participating in CATSS 
when they were aged 9. The second sample comprised participants in the Twins Early 
Development Study (TEDS); TEDS is a sample of twins born in England and Wales between 
1994 and 199616. Data for the present study were collected from TEDS participants when 
twins were aged 8 years. TEDS and CATSS are representative of the populations of England 
and Wales, and Sweden, respectively15-16.  
Both CATSS and TEDS comprise both monozygotic (MZ) and dizygotic (DZ) twins, 
although only DZ twins were included in this study owing to the fact that the genetic 
resemblance of two DZ twins within a pair is the same as the resemblance between two 
singleton siblings (approximately 50% of their segregating DNA code on average). Both 
same-sex and opposite-sex DZ twins were included. In CATSS, families of 6,817 pairs of DZ 
twins returned data, while 4,309 participating families in TEDS returned data. In CATSS, 
exclusions were conducted for known brain injuries and chromosomal syndromes (n=113), 
leaving 6,704 DZ twin pairs. Participants in TEDS were excluded for genetic and 
chromosomal syndromes, extreme perinatal complications, and missing first contact data 
(n=254), leaving 4,055 pairs of DZ twins. Combined, there were 10,759 DZ twin pairs across 
the two samples.  
CATSS has ethical approval from the Karolinska Institutet Ethical Review Board, 
while TEDS has ethical approval from the King’s College London, Institute of Psychiatry, 
Psychology and Neuroscience Ethics Committee.  
Measures 
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In CATSS, the ADHD modules of the Autism-Tics, ADHD, and Other Comorbidities 
inventory (A-TAC)17 were administered to parents of the twins over the telephone. There are 
two ADHD modules, assessing hyperactivity/impulsivity and inattentiveness, comprising a 
total of 19 items that correspond closely to DSM-IV criteria for ADHD1. Each item comprised 
a question, answered “yes” (for a score of 1), “yes, to some extent” (for a score of 0.5), or 
“no” (for a score of 0). Thus, the maximum possible score was 18. In the sample of DZ twins 
used in the present study, the A-TAC ADHD module had strong internal consistency (α = 
.92). A prior study reported strong construct validity for the scale, with 92% sensitivity and 
75% specificity for detecting ADHD18. The A-TAC also comprises two subscales, assessing 
ADHD subtypes: Hyperactivity/Impulsivity (10 items) and Inattention (9 items). 
Parents of twins participating in TEDS completed the ADHD subscale of the 
Conners’ Parent Rating Scale–Revised (Conners ADHD)19. The measure was mailed out to 
parents of the twins, who completed and returned it. Like the A-TAC, the Conners ADHD 
measure comprises 18 items that are closely linked with the DSM-IV criteria for ADHD1. 
Each item comprised a statement in response to which the parents rated, on a 0-3 scale, the 
extent to which each item was true of their children. The maximum possible score was 54. In 
the present study, the Conners ADHD showed strong internal consistency (α = .91). 
Previously, individuals with ADHD have been shown to score more highly on the measure 
than controls19, supporting its construct validity. As with the A-TAC, Conners ADHD 
comprises Hyperactivity/Impulsivity and Inattention subscales (9 items each). 
Data Analysis 
Proband Selection  
In both samples, one twin was randomly selected as the “index twin.” All other twins 
were co-twins. Probands were selected as the index twins scoring within the highest 10% of 
the A-TAC and Conners ADHD distributions, with such a cut-off designed to maximize 
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statistical power while capturing severe-enough cases. Thus, probands in CATSS were 
selected on the basis of A-TAC scores of 6.5 or more, while TEDS probands were defined as 
index twins scoring at least 23 on the Conners ADHD. Subsequently, analyses were repeated 
using more conservative cut-offs of 9.5 on the A-TAC and 28 on the Conners ADHD. These 
cut-offs were designed to capture the highest scoring 5% of each sample, thus testing for a 
female protective effect in relation to even more extreme scores. Due to the lack of sex-
specific diagnostic criteria for ADHD, the same cut-offs were used to select probands, 
regardless of sex. The number of probands, split by sex, is given in Table 1.  
Statistical Analysis 
To test whether co-twins of female probands would display higher ADHD trait scores 
than co-twins of male probands, 3x2 between-subjects analysis of variance (ANOVA) was 
employed. Proband status of the index twin (male proband, female proband, or control) was 
the grouping variable, with co-twins’ ADHD trait scores acting as the outcome variable. An 
omnibus test initially compared scores across co-twins of male probands, female probands, 
and controls, before planned comparisons compared the scores of co-twins of male and 
female probands. Individual p-values were adjusted for multiple comparisons within each 
sample using the Bonferroni correction. All reported p-values are adjusted in this manner. 
Effect sizes were summarized using Cohen’s d. Effect sizes were interpreted using Cohen’s 
criteria20, with d of .20-.49 considered a small effect, .50-.79 medium, and greater than .80 
large.  
To test whether sex of the probands was associated with whether or not their co-twin 
would also be a proband, categorical analyses were employed. Using the above identified cut-
offs, co-twins were classified as either “affected” (i.e., scoring above a given cut-off) or 
“unaffected” (i.e., scoring below a given cut-off). Chi-square tests of association were then 
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used to test whether co-twin status was significantly associated with proband sex. Effect sizes 
were summarized using odds ratios (ORs).  
Analyses were first conducted separately in CATSS and TEDS. To bolster statistical 
power, a third set of analyses was performed on the two samples combined. The Conners 
ADHD and A-TAC were both heavily, positively skewed and were therefore log transformed 
prior to analysis (see Table 2). All co-twin scores used in analyses were standardized by sex 
of the co-twin, thus ensuring that co-twin sex was controlled for and allowing easier 
comparability of findings across samples. All analyses were performed in R21. 
Post hoc analyses subsequently tested for a female protective effect against specific 
ADHD behaviors. All of the analyses detailed above were repeated on the 
Hyperactivity/Impulsivity and Inattention subscales of the A-TAC and Conners ADHD. 
Since these analyses were post hoc, p-values were not adjusted for multiple comparisons. 
RESULTS 
Descriptive statistics for the A-TAC and Conners ADHD are given in Table 2. 
Analysis of Continuous Scores 
Mean standardized scores of co-twins of male probands, female probands, and 
controls are all shown in Figure 1 for the analyses using the 10% cut-offs. In CATSS, scores 
differed significantly across the three groups (F2,6688=79.35, p<.01), with co-twins of female 
probands scoring highest (̅=0.62), followed by co-twins of male probands (̅=0.38), and co-
twins of controls (̅=-0.05). Specifically, co-twins of female probands displayed significantly 
higher A-TAC scores than co-twins of male probands (t6688=-2.84, p<.01), with a modest 
effect size of d=.07.  
Similarly in TEDS, Conners ADHD scores differed significantly across co-twins of 
male probands (̅=0.55), co-twins of female probands (̅=0.79), and co-twins of controls 
(̅=-0.07), F2,4040=102.30, p<.001. Planned contrasts, however, indicated that mean Conners 
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ADHD scores were not significantly elevated in co-twins of female probands relative to co-
twins of male probands (t4040=-2.36, p=.08, d=.07), despite a trend in this direction.  
Merging the two samples produced the same pattern; mean ADHD trait scores 
differed significantly in the three groups (F2,10731=175.90, p<.001), with co-twins of female 
probands showing the highest ADHD trait scores (̅=0.69), followed by co-twins of male 
probands (̅=0.45), and controls (̅=-0.06). The planned contrast confirmed that mean ADHD 
trait scores were significantly higher for co-twins of female probands than co-twins of male 
probands (t10731=-3.73, p<.001, d=.07).  
All mean ADHD trait scores for co-twins of probands selected under the more severe, 
5% cut-offs are given in Table 3. Merging the two samples produced the same pattern of 
results as the 10% cut-off. Index twin status exacted a significant main effect on the mean 
ADHD trait scores of co-twins (F2,10731=95.90, p<.001), with co-twins of female probands 
displaying the highest ADHD trait scores (̅=0.73), followed by co-twins of male probands 
(̅=0.51) and controls (̅=-0.03). Mean ADHD trait scores were significantly elevated in co-
twins of female probands compared with co-twins of male probands (t10731=-2.38, p<.05, 
d=.05).  
Using a 5% cut-off, the same pattern emerged in each individual sample. In CATSS, 
mean A-TAC scores differed significantly across co-twins of male probands (̅=0.43), female 
probands (̅=0.69), and controls (̅=-0.03), F2,6688=46.39, p<.01; however, mean A-TAC 
scores for co-twins of female probands were not significantly higher than mean A-TAC 
scores for co-twins of male probands (t6688=-2.10, p=.16, d=.05). The same result emerged for 
TEDS. While the main effect of index twin status was significant (F2,4040=51.63, p<.001), 
with co-twins of female probands showing the highest mean Conners ADHD scores 
(̅=0.79), followed by co-twins of male probands (̅=0.62) and controls (-0.04), mean 
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Conners ADHD scores for co-twins of female probands were not significantly higher than 
mean scores for co-twins of male probands (t4040=-1.10, p=.27, d=.03).  
Analysis of Categorical Recurrence  
Table 4 shows the number of affected and unaffected co-twins by proband sex for 
each sample and cut-off. Using a 10% cut-off to select probands, the association between 
proband sex and co-twin status was only significant when CATSS and TEDS were merged 
(χ21=5.21, p<.05, OR=0.70 [0.52/0.94]), with a greater proportion of co-twins of female 
probands (29%) than co-twins of male probands (22%) showing higher ADHD trait scores.  
In CATSS, a greater proportion of co-twins of female probands scoring above the 
10% also scored above the cut-off (15% of co-twins of female probands compared with 9% 
of co-twins of male probands. The association was small and non-significant, however 
(χ21=4.67, p=.06, OR=0.57 [0.34/0.92]). Similarly in TEDS, 38% of co-twins of female 
probands scored above the 10% cut-off compared with 29% of co-twins of male probands, 
although this association was again small and failed to reach significance (χ21=3.23, p=.14, 
OR=0.66 [0.43/1.01]).  
The findings followed the same pattern when a cut-off that selected 5% of index twins 
as probands was used. When CATSS and TEDS were merged, there was a significant 
association between proband sex and co-twin status (χ21=6.38, p<-.05, OR=0.54 [0.35/0.86]), 
with a greater proportion of co-twins of female probands (26%) than co-twins of male 
probands (16%) showing a pronounced degree of ADHD traits. In CATSS alone, more co-
twins of female probands (21%) than co-twins of male probands (12%) were affected, yet this 
association was not significant (χ21=3.35, p=.14, OR=0.53 [0.28/0.99]). The same was true of 
TEDS: more co-twins of female probands (33%) than co-twins of male probands (22%) were 
affected, yet this seeming association was not significant (χ21=2.46, p=.24, OR=0.56 
[0.29/1.08]).  
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Subscale Analyses 
Figures 1b and 1c show the mean scores of co-twins of probands on the A-TAC and 
Conners ADHD subscales (Hyperactivity/Impulsivity and Inattention), with probands scoring 
within the highest 10% of the subscales. In CATSS, TEDS, and the combined cohorts, co-
twins of female probands displayed the highest mean Hyperactivity/Impulsivity scores, 
followed by co-twins of male probands and co-twins of controls. In all analyses, the mean 
scores of co-twins of female probands were significantly higher than those of the other two 
groups (p<.05). 
Inattention followed the same pattern, as shown in Figure 1c. Co-twins of female 
probands displayed the highest mean Inattention score, followed by co-twins of male 
probands and co-twins of controls. The mean scores of co-twins of female probands were 
significantly higher than both other groups of co-twins in all three analyses (p<.05).  
These results are shown in full in tables S1-S4, available online.  
DISCUSSION 
This investigation sought to test whether a female protective effect can account for the 
substantially elevated prevalence of ADHD in males relative to females2-4. The results of this 
study lend partial credence to a female protective effect hypothesis for ADHD. In line with 
the results of an existing US study14 and our hypotheses, there was some evidence to indicate 
that the co-twins of females displaying an extreme degree of characteristic ADHD behaviors 
displayed more such behaviors themselves than did the co-twins of males showing an 
extreme degree of ADHD traits. Further, co-twins of females with particularly high ADHD 
trait scores were more likely to display an extreme degree of ADHD behaviors than were the 
co-twins of males. As such, these findings tentatively indicate that a female protective effect 
could be a potentially viable model to aid understanding the development of ADHD. 
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Our findings provide a platform for future research into the genetic basis of ADHD to 
build upon. While twin studies of ADHD have consistently supported its high heritability5-9, 
elucidating the precise genetic mechanisms underpinning ADHD has proven elusive22. The 
female protective effect model provides an opportunity to raise further research questions in 
such research. For example, genes can be divided into high-impact and low-impact sets23. 
One possibility is that females with ADHD are more likely to inherit higher impact genes 
associated with ADHD, which are rarer. To illustrate, ASD also more commonly affects 
males than females24, and recent twin and family studies support a female protective effect 
against ASD12,25. A genetic study then indicated that females with ASD displayed a higher 
degree of larger copy number variants, which were more likely to be maternally inherited11. 
Similar studies of ADHD may well prove useful in furthering our understanding of the 
etiology of ADHD.  
Indeed, while our study did not investigate any specific etiological mechanisms 
associated with ADHD, our findings suggest that investigating the degree of exposure to 
etiological factors associated with ADHD in males and females with the condition may be a 
worthwhile future research direction. While the above example mentioned larger, rarer copy 
number variants, one might also test whether females with ADHD exhibit a greater number 
of smaller, common genetic variants. Indeed, in using polygenic scores, which have yielded 
useful insights in the genetic architecture of ADHD26, one could investigate whether females 
with ADHD display a greater degree of common genetic variants associated with ADHD than 
males with ADHD27.  
One could also extend this to causal environmental factors. While twin studies 
indicate that genetic factors seem to outweigh environmental factors in the etiology of 
ADHD5-9, research has implicated certain environmental exposures with ADHD. For 
instance, lower birth weight is thought to be a causal environmental factor in ADHD28-29. It 
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may be that females with ADHD undergo greater exposure to such factors compared with 
males; for instance, could females with ADHD display an even lower birth weight than males 
with ADHD?  
The presence of a female protective effect against ADHD behaviors also has 
implications for clinical practice. If clinicians take account of family history when diagnosing 
ADHD, it may be beneficial to also account for the sex of any previously affected relatives, 
under the assumption that relatives of females with ADHD are more likely to exhibit ADHD 
symptoms than relatives of males with ADHD. The caveat to this assertion, however, is that 
our findings are based only on twin data. The female protective effect against ADHD needs 
to be replicated in alternative, non-twin samples before such a conclusion can be decisively 
drawn. For instance, a recent study of ASD found that siblings of female non-twins with ASD 
were more likely to have ASD than siblings of male non-twins25. Such studies of non-twin 
relatives are now needed in relation to ADHD. 
It does need to be noted that the overall sizes of the effects reported here, where 
significant, were weak. The effect reported in this paper is less than half the size of the 
female protective effect in relation to autism reported in a similar study12. Indeed, significant 
findings only emerged for the more severe cut-off of 5% when the two samples used were 
merged to create a larger sample. The small effect size seen here is consistent with that 
reported previously14, and so it is quite clear that subsequent studies testing the female 
protective effect model of ADHD are going to need to depend on large samples.  
The small female protective effect seen here does, nevertheless, stress the need not to 
discount alternative explanations for the increased number of males with ADHD relative to 
females. There is very limited research considering phenotypic differences between males 
and females with ADHD. For instance, one study investigated sex differences in ADHD 
across ten European countries, and reported that females with ADHD displayed more 
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emotional difficulties3. Furthermore, the DSM-IV criteria for ADHD, upon which our 
measures were based, are based exclusively on observations of males1, 30-31.  
Two further possibilities cannot be discounted from our study. While our findings 
lend support to the notion of a female protective effect against ADHD, it is not mutually 
exclusive to the hypothesis that males have more risk factors for ADHD. It is also in theory 
possible that rater contrast effects drove the higher scores seen in co-twins of female 
probands. Rater contrast effects refer to the scenario whereby parent ratings of one twin are 
influenced by how they view their co-twin32. To create the observed pattern of results, 
parents would need to have shown a stronger rater contrast effect on the co-twins (who were 
both male and female) of male probands than of female probands. In twin analyses of the A-
TAC and Conners ADHD scale, rater contrast effects have been modeled and shown to be 
modest9,33, suggesting that rater contrast effects are unlikely to be an adequate explanation for 
our findings.     
In addition to the caveat of the small effect size, our study did have further limitations 
that need taking into account. Proband status was ascertained through use of dimensional 
questionnaire measures, as opposed to in-depth assessments of ADHD. The use of this 
approach would, however, have come at the cost of the large sample size. As alluded to 
above, only twins were used in this study. While we removed MZ twins to ensure that the 
genetic relatedness of the relatives in our sample was similar to fraternal siblings, it is 
important to know whether these findings extend to non-twin relatives in future. In defense of 
our use of a twin sample, on the other hand, there is evidence to indicate that ADHD traits are 
not elevated in twins relatives to singletons34. Finally, we did not examine the dimensions of 
hyperactivity/impulsivity and inattentiveness separately. This was intentional; we already had 
conducted numerous statistical tests, necessitating adjustment of p-values for multiple 
comparisons. The inclusion of further comparisons would likely have yielded non-significant 
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results; nonetheless, future studies of the female protective effect against ADHD should 
examine the two core ADHD symptom domains separately.  
Finally, our study did not take comorbidity into account. Females with ADHD are 
more likely to present with additional disorders, such as anxiety and depression, than males 
with ADHD35. If one assumes a certain degree of common causal factors across ADHD and 
other neuropsychiatric disorders, as supported by recent twin studies36-37, then it is possible 
that females manifest with different symptoms at lower levels of exposure to etiological 
factors, with ADHD only emerging after greater exposure. This could be tested in the future 
using ADHD polygenic risk scores, for example.     
To a certain degree, this study indicates that females are protected against behaviors 
characteristic of ADHD. While our findings do not speak to any specific mechanisms through 
which this effect may operate, this study indicates that further research on the female 
protective effect model is warranted in relation to ADHD, with a view to identify the specific 
biological basis of this effect. If the effect holds across multiple epidemiological methods, 
then it represents a plausible explanation for why fewer females than males develop ADHD, 
as well as assisting in the diagnostic process.  
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Table 1 Number of Probands 
 5% 10% 
Measure Sample Male, n (%) Female, n (%) Male, n (%) Female, n (%) 
Total ADHD CATSS 227 (70) 95 (30) 450 (69) 201 (31) 
 TEDS 146 (70) 63 (30) 291 (68) 138 (32) 
 Merged 373 (70) 158 (30) 741 (69) 339 (31) 
Hyperactivity/Impulsivity CATSS 208 (68) 100 (32) 382 (63) 229 (37) 
 TEDS 142 (69) 65 (31) 242 (63) 140 (37) 
 Merged 350 (68) 165 (32) 624 (63) 369 (37) 
Inattention CATSS 238 (69) 109 (31) 468 (66) 237 (34) 
 TEDS 141 (71) 57 (29) 255 (69) 116 (31) 
 Merged 379 (70) 166 (30) 723 (67) 353 (33) 
Note: ADHD = attention-deficit/hyperactivity disorder; CATSS = Child and Adolescent Twin Study in Sweden; TEDS = Twins Early 
Development Study.  
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Table 2 Descriptive Statistics 
Measure Cronbach’s α Possible Range of 
Scores 
 Full Sample 
(SD) 
	Males (SD)  Females (SD) Skew 
A-TAC a .92 0-19 2.10 (3.21) 2.54 (3.54) 1.62 (2.73) 2.34 
Conners ADHD b .91 0-54 10.84 (9.00) 12.67 (9.71) 9.04 (7.85) 1.37 
A-TAC Hyp/Imp c .89 0-10 0.99 (1.69) 1.17 (1.85) 0.81 (1.48) 2.53 
A-TAC Inatten. d .90 0-9 1.03 (1.73) 1.28 (1.91) 0.78 (1.49) 2.23 
Conners Hyp/Imp e .89 0-27 5.57 (4.93) 6.39 (5.28) 4.78 (4.41) 1.33 
Conners Inatten. f .91 0-27 5.27 (5.04) 6.29 (5.45) 4.26 (4.37) 1.41 
Note: ADHD = attention-deficit/hyperactivity disorder; A-TAC = Autism-tics and other comorbidities inventory; Conners ADHD = ADHD 
subscale of the Conners’ Parent Rating Scale; hyp = hyperactivity; imp = impulsivity; inatten = inattention. 
a
 Mean A-TAC scores were significantly higher for males than females in the full sample, t6539.22=11.90, p<-.001, d=.29 
b
 Mean Conners ADHD scores were significantly higher for males than females in the full sample, t3843.64=13.08, p<.001, d=.42 
c
 Mean A-TAC Hyperactivity/Impulsivity scores were significantly higher for males than females in the full sample, t6431.70=8.95, p<.001, d=.22 
d
 Mean A-TAC Inattention scores were significantly higher for males than females in the full sample, t6369.05=12.08, p<.001, d=.30 
e
 Mean Conners ADHD Hyperactivity/Impulsivity scores were significantly higher for males than females in the full sample, t3890.60=10.50, 
d=.34 
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Table 3 Analysis of Continuous Traits of Attention-Deficit/Hyperactivity Disorder (ADHD) in Co-Twins 
5% 
 CATSS TEDS Merged Samples 
Co-Twin of Male Proband  0.43 (1.18) 0.62 (0.89) 0.51 (1.08) 
Co-Twin of Female Proband  0.69 (1.23) 0.79 (1.02) 0.73 (1.15) 
Co-Twin of Control  -0.03 (0.98) -0.04 (0.99) -0.03 (0.99) 
Omnibus ANOVA F2,6688=46.39, p<.01 F2,4040=51.63, p<.001 F2,10731=95.90, p<.001 
Planned Contrast  t6688=-2.10, p=.16, d=.05 t4040=-1.10, p=.27, d=.03 t10731=-2.38, p<.05, d=.05 
10%  
 CATSS TEDS Merged Samples 
Co-Twin of Male Proband  0.38 (1.11) 0.55 (0.89) 0.45 (1.04) 
Co-Twin of Female Proband  0.62 (1.14) 0.79 (0.87) 0.69 (0.79) 
Co-Twin of Control  -0.05 (0.97) -0.07 (0.99) -0.06 (0.98) 
Omnibus ANOVA F2,6688=79.35, p<.01 F2,4040=102.30, p<.001 F2,10731=175.90, p<.001 
Planned Contrast  t6688=-2.84, p<.01, d=.07 t4040=-2.36, p=.08, d=.07 t10731=-3.73, p<.001, d=.07 
Note: Merged Samples are analyses of both Child and Adolescent Twin Study in Sweden (CATSS) and Twins Early Development Study (TEDS), 
merged into a single dataset. Omnibus analysis of variance (ANOVA) is a comparison of all three conditions (co-twins of male probands, co-
twins of female probands, and co-twins of controls); planned contrast is a comparison of co-twins of male probands and co-twins of female 
probands. 
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Table 4 Analyses of Categorical Recurrence Rates 
CATSS 
5% 10% 
 
Co-Twin “Affected”  Co-Twin 
“Unaffected” 
 Co-Twin “Affected”  Co-Twin 
“Unaffected” 
Male Proband 28 (12%) 199 (88%) Male Proband 40 (9%) 410 (91%) 
Female Proband 20 (21%) 75 (79%) Female Proband 30 (15%) 171 (85%) 
 
χ
2
1=3.35, p=.14, OR=0.53 (0.28/0.99)  χ21=4.67, p=.06, OR=0.57 (0.34/0.92) 
TEDS  
5% 10% 
 
Co-Twin “Affected”  Co-Twin 
“Unaffected” 
 Co-Twin “Affected”  Co-Twin 
“Unaffected” 
Male Proband 32 (22%) 114 (78%) Male Proband 83 (29%) 208 (71%) 
Female Proband 21 (33%) 42 (67%) Female Proband 52 (38%) 86 (62%) 
 
χ
2
1=2.46, p=.24, OR=0.56 (0.29/1.08)  χ21=3.23, p=.14, OR=0.66 (0.43/1.01) 
Merged Samples   
5% 10% 
 
Co-Twin “Affected”  Co-Twin 
“Unaffected” 
 Co-Twin “Affected”  Co-Twin 
“Unaffected” 
Male Proband 60 (16%) 313 (84%) Male Proband 163 (22%) 578 (78%) 
Female Proband 41 (26%) 117 (74%) Female Proband 97 (29%) 242 (71%) 
 
χ
2
1=6.38, p<.05, OR=0.54 (0.35/0.86)  χ21=5.21, p<.05, OR=0.70 (0.52/0.94) 
Note: 5% and 10% indicate which cut-off was used to select probands in each analysis (highest scoring 10% of each sample or highest scoring 
5% of each sample). Merged samples are analyses of both Child and Adolescent Twin Study in Sweden (CATSS) and Twins Early Development 
Study (TEDS) merged into a single dataset. 
 
Figure 1: Mean co-twin scores for a) full-scale attention-deficit/hyperactivity disorder (ADHD), b) hyperactivity/impulsivity, and c) inattention 
for the highest scoring 10% in all analyses. Note: CATSS = Child and Adolescent Twin Study in Sweden; TEDS = Twins Early Development 
Study. 
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Supplementary Materials 
 
Table S1 Analyses of Hyperactivity/Impulsivity Continuous Scores 
 
Continuous Scores (5%) 
 CATSS TEDS Merged Samples 
Co-twin of male proband  0.36 (1.19) 0.74 (0.85) 0.51 (1.08) 
Co-twin of female proband  0.72 (1.23) 0.99 (0.85) 0.83 (1.10) 
Co-twin of control  -0.02 (0.98) -0.04 (0.99) -0.03 (0.98) 
Omnibus ANOVA F2,6696=41.65, p<.001 F2,4038=77.06, p<.001 F2,10737=109.60, p<.001 
Planned contrast  t6696=-3.04, p<.01, d=.04 t4038=-1.76, p=.08, d=.05 t10737=-10.06, p<.001, d=.19 
Continuous Scores (10%) 
 CATSS TEDS Merged Samples 
Co-twin of male proband  0.36 (1.18) 0.69 (0.84) 0.49 (1.07) 
Co-twin of female proband  0.52 (1.18) 0.81 (0.90) 0.63 (1.09) 
Co-twin of control  -0.04 (0.97) -0.08 (0.98) -0.06 (0.97) 
Omnibus ANOVA F2,6696=62.08, p<.001 F2,4038=121.20, p<.001 F2,10737=167.30, p<.001 
Planned contrast  t6696=-7.66, p<.001, d=.09 t4038=-11.85, p<.001, d=.37 t10737=-13.31, p<.001, d=.26 
 
Note: ANOVA = analysis of variance; CATSS = Child and Adolescent Twin Study in Sweden; TEDS = Twins Early Development Study. 
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Table S2 Analyses of Hyperactivity/Impulsivity Categorical Recurrence Rates 
CATSS 
5% 10% 
 
“Affected” Co-Twin  “Unaffected” Co-
Twin 
 “Affected” Co-Twin  “Unaffected” Co-
Twin 
Male Proband 23 (11%) 185 (89%) Male Proband 41 (11%) 341 (89%) 
Female Proband 18 (18%) 82 (82%) Female Proband 30 (13%) 199 (87%) 
 
χ
2
1=2.25, p=.13, OR=0.57 (0.29-1.11)  χ21=0.57, p=.45, OR=0.80 (0.48-1.31) 
TEDS  
5% 10% 
 
“Affected” Co-Twin  “Unaffected” Co-
Twin 
 “Affected” Co-Twin  “Unaffected” Co-
Twin 
Male Proband 30 (21%) 112 (79%) Male Proband 62 (25%) 180 (75%) 
Female Proband 19 (29%) 46 (71%) Female Proband 50 (36%) 90 (64%) 
 
χ
2
1=1.20, p=.27, OR=0.64 (0.33-1.27)  χ21=3.89, p=.05, OR=0.62 (0.40-0.97) 
Merged Samples   
5% 10% 
 
“Affected” Co-Twin  “Unaffected” Co-
Twin 
 “Affected” Co-Twin  “Unaffected” Co-
Twin 
Male Proband 53 (15%) 297 (85%) Male Proband 131 (21%) 493 (79%) 
Female Proband 37 (22%) 128 (78%) Female Proband 101 (27%) 268 (73%) 
 
χ
2
1=3.63, p=.06, OR=0.68 (0.39-0.99)  χ21=4.92, p<.05, OR=0.71 (0.52-0.95) 
 
Note: CATSS = Child and Adolescent Twin Study in Sweden; OR = odds ratio; TEDS = Twins Early Development Study. 
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Table S3 Analyses of Inattention Continuous Scores 
5% 
 CATSS TEDS Merged Samples 
Co-twin of male proband  0.30 (1.09) 0.31 (1.01) 0.30 (1.06) 
Co-twin of female proband  0.57 (1.28) 0.44 (1.15) 0.53 (1.24) 
Co-twin of control  -0.02 (0.99) -0.02 (0.99) -0.02 (0.99) 
Omnibus ANOVA F2,6691=29.71, p<.001 F2,4038=13.17, p<.001 F2,10732=42.56, p<.001 
Planned contrast  t6691=-2.37, p<.05, d=.03 t4038=-0.84, p=.40, d=.03 t10732=-6.18, p<.001, d=.12 
10% 
 CATSS TEDS Merged Samples 
Co-twin of male proband  0.26 (1.09) 0.39 (0.97) 0.31 (1.05) 
Co-twin of female proband  0.46 (1.20) 0.51 (1.00) 0.48 (1.13) 
Co-twin of control  -0.04 (0.98) -0.04 (0.99) -0.04 (0.98) 
Omnibus ANOVA F2,6691=46.07, p<.001 F2,4038=38.50, p<.001 F2,10732=83.02, p<.001 
Planned contrast  t6691=-6.28, p<.001, d=.15 t4038=-6.75, p<.001, d=.21 t10732=-9.06, p<.001, d=.17 
 
Note: ANOVA = analysis of variance; CATSS = Child and Adolescent Twin Study in Sweden; TEDS = Twins Early Development Study. 
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Table S4 Analyses of Inattention Categorical Recurrence Rates 
CATSS 
5% 10% 
 
“Affected” Co-Twin  “Unaffected” Co-
Twin 
 “Affected” Co-Twin  “Unaffected” Co-
Twin 
Male Proband 22 (9%) 216 (91%) Male Proband 80 (17%) 388 (83%) 
Female Proband 22 (20%) 87 (80%) Female Proband 56 (26%) 181 (74%) 
 
χ
2
1=7.12, p<.05, OR=0.40 (0.21-0.76)  χ21=3.91, p=.05, OR=0.67 (0.45-0.98) 
TEDS  
5% 10% 
 
“Affected” Co-Twin  “Unaffected” Co-
Twin 
 “Affected” Co-Twin  “Unaffected” Co-
Twin 
Male Proband 14 (10%) 127 (90%) Male Proband 45 (18%) 210 (82%) 
Female Proband 13 (23%) 44 (77%) Female Proband 30 (26%) 86 (74%) 
 
χ
2
1=4.67, p<.05, OR=0.37 (0.16-0.85)  χ21=2.85, p=.09, OR=0.61 (0.36-1.04) 
Merged Samples   
5% 10% 
 
“Affected” Co-Twin  “Unaffected” Co-
Twin 
 “Affected” Co-Twin  “Unaffected” Co-
Twin 
Male Proband 36 (9%) 343 (91%) Male Proband 125 (17%) 598 (83%) 
Female Proband 35 (21%) 131 (79%) Female Proband 86 (32%) 267 (68%) 
 
χ
2
1=12.67, p<.001, OR=0.39 (0.24-0.65)  χ21=7.09, p<.05, OR=0.65 (0.48-0.89) 
Note: CATSS = Child and Adolescent Twin Study in Sweden; OR = odds ratio; TEDS = Twins Early Development Study. 
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